中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
27期
36-37
,共2页
克林霉素%支原体肺炎%患儿%阿奇霉素
剋林黴素%支原體肺炎%患兒%阿奇黴素
극림매소%지원체폐염%환인%아기매소
Clindamycin%Mycoplasma pneumonia%Child patient%Azithromycin
目的：探讨和研究克林霉素治疗小儿支原体肺炎的临床疗效。方法摘取该院自2009年1月-2013年1月之间所收治的88例支原体肺炎患儿的临床资料作为对象进行研究，按照随机分组的方式将以上患儿分为观察组44例和对照组44例，其中对照组单纯采用阿奇霉素进行治疗，观察组则在此基础上加用克林霉素进行治疗，对两组患儿的疗效进行统计对比。结果疗效显示观察组的总有效率为95.5%与显效率61.3%均显著优于对照组的81.8%、36.3%，差异有统计学意义(P<0.05)，从不良反应方面来看，观察组6.8%对照组9.1%，对比差异无统计学意义(P>0.05)。结论克林霉素治疗小儿支原体肺炎的疗效显著，联合阿奇霉素应用的效果显著优于单纯采用阿奇霉素进行治疗，值得在临床上加以推广和应用。
目的：探討和研究剋林黴素治療小兒支原體肺炎的臨床療效。方法摘取該院自2009年1月-2013年1月之間所收治的88例支原體肺炎患兒的臨床資料作為對象進行研究，按照隨機分組的方式將以上患兒分為觀察組44例和對照組44例，其中對照組單純採用阿奇黴素進行治療，觀察組則在此基礎上加用剋林黴素進行治療，對兩組患兒的療效進行統計對比。結果療效顯示觀察組的總有效率為95.5%與顯效率61.3%均顯著優于對照組的81.8%、36.3%，差異有統計學意義(P<0.05)，從不良反應方麵來看，觀察組6.8%對照組9.1%，對比差異無統計學意義(P>0.05)。結論剋林黴素治療小兒支原體肺炎的療效顯著，聯閤阿奇黴素應用的效果顯著優于單純採用阿奇黴素進行治療，值得在臨床上加以推廣和應用。
목적：탐토화연구극림매소치료소인지원체폐염적림상료효。방법적취해원자2009년1월-2013년1월지간소수치적88례지원체폐염환인적림상자료작위대상진행연구，안조수궤분조적방식장이상환인분위관찰조44례화대조조44례，기중대조조단순채용아기매소진행치료，관찰조칙재차기출상가용극림매소진행치료，대량조환인적료효진행통계대비。결과료효현시관찰조적총유효솔위95.5%여현효솔61.3%균현저우우대조조적81.8%、36.3%，차이유통계학의의(P<0.05)，종불량반응방면래간，관찰조6.8%대조조9.1%，대비차이무통계학의의(P>0.05)。결론극림매소치료소인지원체폐염적료효현저，연합아기매소응용적효과현저우우단순채용아기매소진행치료，치득재림상상가이추엄화응용。
Objective To investigate and study the clinical efficacy of clindamycin in the treatment of mycoplasma pneumonia in children. Methods The clinical data of 88 children with mycoplasma pneumonia admitted in our hospital from January 2009 to January 2013 were selected as the subjects. And the children were randomly divided into the observation group and the control group with 44 children in each. The control group was treated by azithromycin, and the observation group was treated by clin-damycin on the basis of azithromycin. The efficacies of the two groups of children were counted and compared. Results The effica-cies of the groups showed that the total effective rate and markedly effective rate of the observation group was 95.5%, 61.3%, re-spectively, higher than 81.8%, 36.3%of the control group, respectively, the differences were statistically significant (P<0.05). The incidence of adverse reactions of the observation group was 6.8%, and that of the control group was 9.1%, the difference was not statistically significant (P>0.05). Conclusion Clindamycin is quite effective in the treatment of children with mycoplasma pneumo-nia. The effect of clindamycin combined with azithromycin is much better than that of azithromycin, and it is worthy of promotion and application in clinical practice.
